Home Other Building Blocks Cyclo(.alpha.R)-.alpha.-hydroxy-4-(4-morpholinyl)benzenepropanoyl-N-methyl-L-leucyl-(2R)-2-hydroxypropanoyl-N-methyl-L-leucyl-(.alpha.R)-.alpha.-hydroxy-4-(4-morpholinyl)benzenepropanoyl-N-methyl-L-leucyl-(2R)-2-hydroxypropanoyl-N-methyl-L-leucyl

Cyclo(.alpha.R)-.alpha.-hydroxy-4-(4-morpholinyl)benzenepropanoyl-N-methyl-L-leucyl-(2R)-2-hydroxypropanoyl-N-methyl-L-leucyl-(.alpha.R)-.alpha.-hydroxy-4-(4-morpholinyl)benzenepropanoyl-N-methyl-L-leucyl-(2R)-2-hydroxypropanoyl-N-methyl-L-leucyl

CAS No.:
155030-63-0
Catalog Number:
AG00ASRW
Molecular Formula:
C60H90N6O14
Molecular Weight:
1119.3884
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
98%
1 week
United States
$357
- +
10mg
98%
1 week
United States
$523
- +
50mg
98%
1 week
United States
$1523
- +
100mg
98%
1 week
United States
$2473
- +
Product Description
Catalog Number:
AG00ASRW
Chemical Name:
Cyclo(.alpha.R)-.alpha.-hydroxy-4-(4-morpholinyl)benzenepropanoyl-N-methyl-L-leucyl-(2R)-2-hydroxypropanoyl-N-methyl-L-leucyl-(.alpha.R)-.alpha.-hydroxy-4-(4-morpholinyl)benzenepropanoyl-N-methyl-L-leucyl-(2R)-2-hydroxypropanoyl-N-methyl-L-leucyl
CAS Number:
155030-63-0
Molecular Formula:
C60H90N6O14
Molecular Weight:
1119.3884
MDL Number:
MFCD09837720
IUPAC Name:
(3S,6R,9S,12R,15S,18R,21S,24R)-4,6,10,16,18,22-hexamethyl-3,9,15,21-tetrakis(2-methylpropyl)-12,24-bis[(4-morpholin-4-ylphenyl)methyl]-1,7,13,19-tetraoxa-4,10,16,22-tetrazacyclotetracosane-2,5,8,11,14,17,20,23-octone
InChI:
InChI=1S/C60H90N6O14/c1-37(2)31-47-57(71)77-41(9)53(67)61(11)50(34-40(7)8)60(74)80-52(36-44-17-21-46(22-18-44)66-25-29-76-30-26-66)56(70)64(14)48(32-38(3)4)58(72)78-42(10)54(68)62(12)49(33-39(5)6)59(73)79-51(55(69)63(47)13)35-43-15-19-45(20-16-43)65-23-27-75-28-24-65/h15-22,37-42,47-52H,23-36H2,1-14H3/t41-,42-,47+,48+,49+,50+,51-,52-/m1/s1
InChI Key:
ZMQMTKVVAMWKNY-YSXLEBCMSA-N
SMILES:
CC(C[C@H]1C(=O)O[C@H](Cc2ccc(cc2)N2CCOCC2)C(=O)N(C)[C@H](CC(C)C)C(=O)O[C@H](C)C(=O)N(C)[C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N1C)C)CC(C)C)C)Cc1ccc(cc1)N1CCOCC1)CC(C)C)C
EC Number:
604-993-7
UNII:
YZ647Y5GC9
Properties
Complexity:
1900  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
8  
Defined Bond Stereocenter Count:
0
Exact Mass:
1118.652g/mol
Formal Charge:
0
Heavy Atom Count:
80  
Hydrogen Bond Acceptor Count:
16  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
1119.408g/mol
Monoisotopic Mass:
1118.652g/mol
Rotatable Bond Count:
14  
Topological Polar Surface Area:
211A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
9  
Literature
Title Journal
Identification of a nonsense mutation in feline ABCB1. Journal of veterinary pharmacology and therapeutics 20151001
Treatment of third-stage larvae of Toxocara cati with milbemycin oxime plus praziquantel tablets and emodepside plus praziquantel spot-on formulation in experimentally infected cats. Parasitology research 20121101
[New drugs for small animals in 2011]. Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere 20121017
Emodepside and SL0-1 potassium channels: a review. Experimental parasitology 20120901
Anthelmintic cyclcooctadepsipeptides: complex in structure and mode of action. Trends in parasitology 20120901
Levamisole receptors: a second awakening. Trends in parasitology 20120701
Decreased emodepside sensitivity in unc-49 γ-aminobutyric acid (GABA)-receptor-deficient Caenorhabditis elegans. International journal for parasitology 20120701
Morphea-like lesion following topical endectocide application in a cat. Veterinary dermatology 20120601
Worms take to the slo lane: a perspective on the mode of action of emodepside. Invertebrate neuroscience : IN 20120601
A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS neglected tropical diseases 20120401
Perfusion calorimetry in the characterization of solvates forming isomorphic desolvates. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20110918
On the mode of action of emodepside: slow effects on membrane potential and voltage-activated currents in Ascaris suum. British journal of pharmacology 20110901
Efficacy of emodepside plus toltrazuril (Procox(®) oral suspension for dogs) against Toxocara canis, Uncinaria stenocephala and Ancylostoma caninum in dogs. Parasitology research 20110801
Efficacy of emodepside plus toltrazuril suspension (Procox(®) oral suspension for dogs) against prepatent and patent infection with Isospora canis and Isospora ohioensis-complex in dogs. Parasitology research 20110801
Field evaluations of the efficacy and safety of Emodepside plus toltrazuril (Procox® oral suspension for dogs) against naturally acquired nematode and Isospora spp. infections in dogs. Parasitology research 20110801
Efficacy of emodepside/toltrazuril suspension (Procox® oral suspension for dogs) against mixed experimental Isospora felis/Isospora rivolta infection in cats. Parasitology research 20110801
Efficacy of Procox® oral suspension for dogs (0.1% emodepside and 2% toltrazuril) against experimental nematode (Toxocara cati and Ancylostoma tubaeforme) infections in cats. Parasitology research 20110801
Differences in efficacy of monepantel, derquantel and abamectin against multi-resistant nematodes of sheep. Parasitology research 20110701
Selective toxicity of the anthelmintic emodepside revealed by heterologous expression of human KCNMA1 in Caenorhabditis elegans. Molecular pharmacology 20110601
Potential drug development candidates for human soil-transmitted helminthiases. PLoS neglected tropical diseases 20110601
SLO-1-channels of parasitic nematodes reconstitute locomotor behaviour and emodepside sensitivity in Caenorhabditis elegans slo-1 loss of function mutants. PLoS pathogens 20110401
On being the right size: the impact of population size and stochastic effects on the evolution of drug resistance in hospitals and the community. PLoS pathogens 20110401
Are we paying too much attention to cardio-pulmonary nematodes and neglecting old-fashioned worms like Trichuris vulpis? Parasites & vectors 20110101
Oral dosing with papaya latex is an effective anthelmintic treatment for sheep infected with Haemonchus contortus. Parasites & vectors 20110101
Glutamate-gated chloride channels of Haemonchus contortus restore drug sensitivity to ivermectin resistant Caenorhabditis elegans. PloS one 20110101
A differential role for neuropeptides in acute and chronic adaptive responses to alcohol: behavioural and genetic analysis in Caenorhabditis elegans. PloS one 20100101
Canine and feline cardiopulmonary parasitic nematodes in Europe: emerging and underestimated. Parasites & vectors 20100101
Efficacy of emodepside plus praziquantel tablets (Profender tablets for dogs) against mature and immature infections with Toxocara canis and Toxascaris leonina in dogs. Parasitology research 20090801
Efficacy of emodepside plus praziquantel tablets (Profender tablets for dogs) against mature and immature adult Ancylostoma caninum and Uncinaria stenocephala infections in dogs. Parasitology research 20090801
Efficacy of emodepside plus praziquantel tablets (Profender tablets for dogs) against mature and immature adult Trichuris vulpis infections in dogs. Parasitology research 20090801
Field evaluation of the efficacy and safety of emodepside plus praziquantel tablets (Profender tablets for dogs) against naturally acquired nematode and cestode infections in dogs. Parasitology research 20090801
Efficacy of emodepside plus praziquantel tablets (Profender tablets for dogs) against mature and immature cestode infections in dogs. Parasitology research 20090801
Treatment and prevention of vertical transmission of Toxocara cati in cats with an emodepside/praziquantel spot-on formulation. Parasitology research 20090801
Efficacy and safety of emodepside 2.1%/praziquantel 8.6% spot-on formulation in the treatment of feline aelurostrongylosis. Parasitology research 20090801
The putative cyclooctadepsipeptide receptor depsiphilin of the canine hookworm Ancylostoma caninum. Parasitology research 20090801
FMRFamide-like neuropeptides as putative ligands of the latrophilin-like HC110-R from Haemonchus contortus. Molecular and biochemical parasitology 20090401
Effects of SDPNFLRF-amide (PF1) on voltage-activated currents in Ascaris suum muscle. International journal for parasitology 20090201
The study of different solid forms of Emodepside. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20090101
Onchocerciasis Control: Vision for the Future from a Ghanian perspective. Parasites & vectors 20090101
Onchocerciasis control: biological research is still needed. Parasite (Paris, France) 20080901
Developing novel anthelmintics from plant cysteine proteinases. Parasites & vectors 20080101
The calcium-activated potassium channel, SLO-1, is required for the action of the novel cyclo-octadepsipeptide anthelmintic, emodepside, in Caenorhabditis elegans. International journal for parasitology 20071201
SLO, SLO, quick, quick, slow: calcium-activated potassium channels as regulators of Caenorhabditis elegans behaviour and targets for anthelmintics. Invertebrate neuroscience : IN 20071201
Effects of the novel anthelmintic emodepside on the locomotion, egg-laying behaviour and development of Caenorhabditis elegans. International journal for parasitology 20070501
Insecticidal toxins from black widow spider venom. Toxicon : official journal of the International Society on Toxinology 20070315
Mechanisms of action of emodepside. Parasitology research 20051001
Influence of the cyclooctadepsipeptides PF1022A and PF1022E as natural products on the design of semi-synthetic anthelmintics such as emodepside. Parasitology research 20051001
Cyclohexadepsipeptides (CHDPs) with improved anthelmintical efficacy against the gastrointestinal nematode (Haemonchus contortus) in sheep. Parasitology research 20051001
Putative G protein-coupled receptors in parasitic nematodes--potential targets for the new anthelmintic class cyclooctadepsipeptides? Parasitology research 20051001
Evaluation of the efficacy of emodepside+praziquantel topical solution against cestode (Dipylidium caninum, Taenia taeniaeformis, and Echinococcus multilocularis) infections in cats. Parasitology research 20051001
Evaluation of the efficacy of emodepside plus praziquantel topical solution against ascarid infections (Toxocara cati or Toxascaris leonina) in cats. Parasitology research 20051001
Efficacy of a topically administered combination of emodepside and praziquantel against mature and immature Ancylostoma tubaeforme in domestic cats. Parasitology research 20051001
Field evaluation of the efficacy and safety of emodepside/praziquantel spot-on solution against naturally acquired nematode and cestode infections in domestic cats. Parasitology research 20051001
Effects of a combinations of emodepside and praziquantel on parasites of reptiles and rodents. Parasitology research 20051001
Efficacy of two cyclooctadepsipeptides, PF1022A and emodepside, against anthelmintic-resistant nematodes in sheep and cattle. Parasitology 20050301
Latrotoxin receptor signaling engages the UNC-13-dependent vesicle-priming pathway in C. elegans. Current biology : CB 20040810
Cyclooctadepsipeptides--an anthelmintically active class of compounds exhibiting a novel mode of action. International journal of antimicrobial agents 20030901
The effect of the anthelmintic emodepside at the neuromuscular junction of the parasitic nematode Ascaris suum. Parasitology 20030101
Cyclooctadepsipeptides--a new class of anthelmintically active compounds. Parasitology research 20020601
Activity of the cyclic depsipeptide emodepside (BAY 44-4400) against larval and adult stages of nematodes in rodents and the influence on worm survival. Parasitology research 20011101
Properties